Registered Zambia · ZAMRA

Mycobind Powder Feed Additive

Montmorillonite-Aluminium-magnesium Silicate

397/728V

What it does

Silicate is a substance used in various treatments, often related to digestive health and mineral supplementation.

Commonly used for: digestive issues, mineral supplementation

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
397/728V
Registration date
2021-08-18
Expiry date
2026-08-17
Status
Registered/Compliant
Active ingredient
Montmorillonite-Aluminium-magnesium Silicate
Dosage form
-
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Farmers Centre
Applicant / LTR
FARMERS CENTRE LTD
Country of origin
Tanzania
Manufacturer location
Uhuru St, Dar es Salaam, Tanzania

Source: Zambia Medicines Regulatory Authority · fetched 2026-03-11 23:59:39 · updated 2026-08-10 03:31:01

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About this medicine

Silicate is a substance used in various treatments, often related to digestive health and mineral supplementation.

What it treats

  • digestive issues
  • mineral supplementation

How it works

Silicate helps to improve gut health and provides essential minerals to the body.

Who it's for

Adults and children who need support for digestion or mineral intake.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: silicate

BNF-referenced

Silicate refers to a group of minerals composed primarily of silicon and oxygen, often found in various forms such as silicate salts. They are widely used in multiple applications, including construction, ceramics, and in some medicinal formulations. In a clinical context, silicates may be employed in the treatment of certain gastrointestinal disorders due to their adsorbent properties.

Indications

  • Diarrhea
  • Gastrointestinal infections
  • Toxin elimination

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines as they are dependent on the formulation and condition being treated.

Adults: Refer to the BNF for specific dosing guidelines as they are dependent on the formulation and condition being treated.

Mechanism of action

Silicates function by adsorbing toxins and pathogens in the gastrointestinal tract, thereby reducing their absorption into the systemic circulation. This mechanism is particularly beneficial in conditions such as diarrhea or gastrointestinal infections, where the reduction of harmful substances can help alleviate symptoms.

Pharmacodynamics

The pharmacodynamics of silicates are characterized by their ability to bind with various substances in the gut, including toxins, bacteria, and other pathogens. This binding helps in reducing the irritative effects of these substances on the intestinal lining and can assist in normalizing bowel function.

Pharmacokinetics

Silicates are generally not absorbed systemically after oral administration. They act locally within the gastrointestinal tract, where they exert their effects. Due to their physical properties, they can remain in the gut for prolonged periods, enhancing their efficacy in adsorbing harmful agents.

Pregnancy

There is limited data on the use of silicates during pregnancy. It is advisable to avoid use unless clearly needed.

Breast-feeding

Silicates are not known to be excreted in human milk. Caution is advised when using.

Storage

Store in a cool, dry place, away from direct sunlight.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: silicate

PubChem CID 104812

Molecular formula: O4Si-4

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.